Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-05-02 Centrally acting antihypertensive drugs
| Methyldopa |
|
Formulary
|
Tablets 125mg, 250mg, 500mg |
 NG133: Hypertension in pregnancy: diagnosis and management |
|
| Moxonidine |
|
Formulary
|
Tablets 200micrograms, 300micrograms, 400micrograms
|
|
Restricted to use in resistant hypertension| Clonidine Hydrochloride |
|
Formulary
|
Tablets 25 microgram
|
 LSCMMG: Clonidine for VMS associated with menopause NMR |
|
|
Vasomotor symptoms (VMS) associated with menopause
Clonidine is considered less suitable for prescribing in hypertensionLinks
Enoxaparin for Treatment of Venous Thromboembolism **FOR USE IN THE BLACKPOOL REGION ONLY** - Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**
- Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY*
- LSC Hypertension in Adults: Diagnosis and Management
- LSC Patient Pathway for Commencing Inclisiran
- LSC Statin Intolerance Pathway
- LSCMMG: Atrial Fibrillation Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease
- LSCMMG: Clonidine for VMS associated with menopause NMR
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG185: Acute Coronary Syndromes
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG196: Atrial fibrillation: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE TA731:Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
- Policy and procedure for prophylaxis against, and treatment of, VTE in adult patients **FOR USE IN THE CENTRAL LANCS REGION ONLY**
- Prevention of VTE in Medical Surgical Patients (16 years +) and those requiring lower limb plaster casts/immobilisations **FOR USE IN THE BLACKPOOL REGION ONLY**
- Renal: Enhanced Supportive Kidney Care Guideline